Bita Mesgarpour

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Topics

Cervical Cancer Screening

Acinetobacter Baumannii

Top Venues

BMC pharmacology & toxicology

International journal of health policy and management

Archives of Iranian medicine

Pharmacoepidemiology and drug safety

This page only lists publications with an associated author ORCID identifier.

Publications

Bita Mesgarpour, Shabnam Faridfar, Mahya Rezaei, Akbar Abdollahiasl, Shahin Shadnia, Arezou Mahdavinejad, Mohammad Abdollahi
Age- and gender-specific acute poisoning with drugs and medications affecting nervous system. BMC pharmacology & toxicology 25 (1) (2024)
Bita Mesgarpour, Shabnam Faridfar, Mahya Rezaei, Akbar Abdollahiasl, Shahin Shadnia, Arezou Mahdavinejad, Mohammad Abdollahi
Age- and gender-specific acute poisoning with drugs and medications affecting nervous system. BMC pharmacology & toxicology 25 (1) (2024)
Bita Mesgarpour, Shabnam Faridfar, Mahya Rezaei, Akbar Abdollahiasl, Shahin Shadnia, Arezou Mahdavinejad, Mohammad Abdollahi
Age- and gender-specific acute poisoning with drugs and medications affecting nervous system. BMC pharmacology & toxicology 25 (1) (2024)
Mohammad Reza Akbari, Alireza Kamalipour, Mahsa Pakroo, Bita Mesgarpour, Hossein Poustchi, Zahra Mohammadi, Abdullah Gandomkar, Hossein Molavi Vardanjani
Prevalence and Correlates of Polypharmacy, and Drug Utilization Pattern in a Semi-urban Population: Results from the Pars Cohort Study. Archives of Iranian medicine 26 (3) (2023)
Bahareh Yazdizadeh, Ehsani-Chimeh Elham, Kazem Zendehdel, Mohammadreza Mobinizadeh, Bita Mesgarpour, Zeinab Fakoorfard
Knowledge gaps and national research priorities for COVID-19 in Iran. Health research policy and systems 20 (1) (2022)
Ali Kabir, Ahmad Sofi-Mahmudi, Arman Karimi Behnagh, Vahid Eidkhani, Hamid Reza Baradaran, Payam Kabiri, Ali Akbar Haghdoost, Bita Mesgarpour
Risk of Bias in Iranian Randomized Trials Included in Cochrane Reviews. Archives of Iranian medicine 25 (6) (2022)
Hossein Hatami, Giovanni Sotgiu, Narjess Bostanghadiri, Sahel Shafiee Dolat Abadi, Bita Mesgarpour, Hossein Goudarzi, Giovanni Battista Migliori, Mohammad Javad Nasiri
Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis. Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 48 (2) (2022)
Mohammad Dehghani, Mehdi Kahouei, Shahin Akhondzadeh, Bita Mesgarpour, Reza Ferdousi
Expectations of Health Researchers From Academic Social Network Sites: Qualitative Study. Journal of medical Internet research 23 (12) (2021)
Malahat Khalili, Bita Mesgarpour, Hamid Sharifi, Asieh Golozar, Ali Akbar Haghdoost
Estimation of adverse drug reaction reporting in Iran: Correction for underreporting. Pharmacoepidemiology and drug safety 30 (8) (2021)
Malahat Khalili, Hamid Sharifi, Bita Mesgarpour, Mehrnaz Kheirandish, Sten Olsson, Naghmeh Javidnikou, Ali Akbar Haghdoost
Evaluation of Pharmacovigilance System in Iran. International journal of health policy and management (2020)
Bita Mesgarpour, Sara Aghababa, Hamid Reza Baradaran, Payam Kabiri, Ali Kabir, Ahmad Sofi-Mahmudi, Ali Akbar Haghdoost
Achievements of the Cochrane Iran Associate Centre: Lessons Learned. International journal of health policy and management 9 (6) (2020)
Malahat Khalili, Bita Mesgarpour, Hamid Sharifi, Samira Daneshvar Dehnavi, Ali Akbar Haghdoost
Interventions to improve adverse drug reaction reporting: A scoping review. Pharmacoepidemiology and drug safety 29 (9) (2020)